Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Diabetes, Obesity & Metabolism|March 7, 2025
Impact of healthy lifestyles on the risk of metabolic dysfunction-associated steatotic liver disease among adults with comorbid hypertension and diabetes: Novel insight from a largely middle-aged and elderly cohort in South ChinaJun-Yan Xi, Yi-Jing Wang, Xiao-Heng Li, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2012
Discovery of thiadiazole amides as potent, S1P₃-sparing agonists of sphingosine-1-phosphate 1 (S1P₁) receptorHeng Xu, Haibo Zhang, Linbo Luan, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2012
Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonistsQinghua Meng, Baowei Zhao, Qiongfeng Xu, et al.
ACS Medicinal Chemistry Letters|April 21, 2016
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating DisordersHeng Xu, Hongfu Lu, Zhongmiao Xu, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
From RORγt Agonist to Two Types of RORγt Inverse AgonistsYonghui Wang, Wei Cai, Ting Tang, et al.
Journal of Medicinal Chemistry|April 17, 2012
Discovery of novel 1,2,4-thiadiazole derivatives as potent, orally active agonists of sphingosine 1-phosphate receptor subtype 1 (S1P(1))Feng Ren, Guanghui Deng, Hailong Wang, et al.
Journal of Medicinal Chemistry|March 5, 2004
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptorKatherine L Widdowson, John D Elliott, Daniel F Veber, et al.
Bioorganic & Medicinal Chemistry|August 17, 2015
Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonistsYonghui Wang, Ting Yang, Qian Liu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 29, 2023
A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinomaQian Liang, Miaomiao Gong, Jing-Hua Zou, et al.
Cancer Research|October 4, 2022
Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung AdenocarcinomaMing-Yu Luo, Ye Zhou, Wei-Ming Gu, et al.
Pageof 18